« Chief Operating Officer Appointed | Main | New Aquila Website Launch »
Wednesday
Nov302011

Aquila R&D Strategy Announced

DateWednesday, November 30, 2011 at 9:21AM

Today Aquila announces its core Research and Development Strategy in the areas of MS, Autoimmune disease, Inflammation and Pain which will underpin the focus of the company over the next year. This will provide a unique service platform for the development of compounds within these therapeutic areas.

AuthorAquila Biomedical | CommentPost a Comment |

PrintView Printer Friendly Version

EmailEmail Article to Friend

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

Notify me of follow-up comments via email.